A small medtech company with a needle-free ambition.

Nemaura Medical Inc. was incorporated in Nevada in 2013, although some secondary profiles cite 2011 as its founding year. Its operating history also follows earlier work within related companies focused on transdermal delivery and diagnostic technologies.

Its flagship concept, sugarBEAT®, uses a flexible skin patch and a reusable transmitter to obtain and communicate glucose trend information without an inserted sensor filament. The company later extended this device idea into digital coaching programs such as proBEAT™ and BEAT® diabetes.

The business has remained small and development-led. Its commercial strategy has emphasized regulatory approvals, licensing arrangements, pilot programs, strategic partners, contract manufacturing and market-by-market scale-up.

Historically based at Loughborough Science Park in the United Kingdom, the organization is best understood as a development-to-commercialization medtech company rather than a mature, broadly scaled device manufacturer.